Mealey's PI/Product Liability - Metoclopramide Plaintiff Fails To Evade Preemption In 5th Circuit Appeal

Mealey's PI/Product Liability - Metoclopramide Plaintiff Fails To Evade Preemption In 5th Circuit Appeal

NEW ORLEANS - A Fifth Circuit U.S. Court of Appeals panel on May 13 affirmed summary judgment for both brand-name and generic manufacturers of metoclopramide, finding that the plaintiff did not find a way around U.S. Supreme Court preemption rulings (Roy Eckhardt, et al. v. Qualitest Pharmaceuticals, Incorporated, et al., No. 13-40151, 5th Cir.).

Find full version on lexis Advance®
Access this news story on lexis.com®